$SRPT So what do you guys think? No update on golodirsen at all. No way forward, nothing. Not even if there IS a way to move forward. I mean, sure, they got a lot of great stuff in their pipeline, but if golodirsen rejection was enough to sink the stock value to almost half it must be a pretty important drug?